Inequity in smoking cessation clinical trials testing pharmacotherapies: exclusion of smokers with mental health disorders | Tobacco Control

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Anniversary

Archive

Authors

Blog

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

PDF +
Supplementary
Material

Review

Inequity in smoking cessation clinical trials testing pharmacotherapies: exclusion of smokers with mental health disorders

Online download statistics by month:

Online download statistics by month: December 2021 to May 2023

	Abstract	Full	Pdf
Dec 2021	889	870	139
Jan 2022	465	457	45
Feb 2022	266	255	52
Mar 2022	240	235	36
Apr 2022	173	168	26
May 2022	193	184	22
Jun 2022	165	161	15
Jul 2022	147	138	11
Aug 2022	221	215	19
Sep 2022	156	155	25
Oct 2022	166	154	24
Nov 2022	152	146	11
Dec 2022	166	159	17
Jan 2023	142	137	15
Feb 2023	138	137	14
Mar 2023	180	172	10
Apr 2023	118	108	18
May 2023	45	40	17
Total	4022	3891	516